{"id":"https://openalex.org/W6958657334","doi":"https://doi.org/10.6084/m9.figshare.29891767","title":"Late apoptotic effects after treatment with 177Lu-octreotate in small-intestine neuroendocrine GOT1 tumor model","display_name":"Late apoptotic effects after treatment with 177Lu-octreotate in small-intestine neuroendocrine GOT1 tumor model","publication_year":2025,"publication_date":"2025-01-01","ids":{"openalex":"https://openalex.org/W6958657334","doi":"https://doi.org/10.6084/m9.figshare.29891767"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/29891767","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Late_apoptotic_effects_after_treatment_with_sup_177_sup_Lu-octreotate_in_small-intestine_neuroendocrine_GOT1_tumor_model/29891767","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Late_apoptotic_effects_after_treatment_with_sup_177_sup_Lu-octreotate_in_small-intestine_neuroendocrine_GOT1_tumor_model/29891767","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020558742","display_name":"Mikael Elvborn","orcid":"https://orcid.org/0000-0002-5470-1377","observed_orcids":["https://orcid.org/0000-0002-5470-1377"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elvborn, Mikael","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079132304","display_name":"Nishte Rassol","orcid":"https://orcid.org/0009-0005-2982-3275","observed_orcids":["https://orcid.org/0009-0005-2982-3275","https://orcid.org/0000-0001-9187-5002"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rassol, Nishte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041788565","display_name":"Daniella Pettersson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pettersson, Daniella","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081675549","display_name":"Emman Shubbar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shubbar, Emman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048819262","display_name":"Johan K. E. Spetz","orcid":"https://orcid.org/0000-0002-5216-9786","observed_orcids":["https://orcid.org/0000-0002-5216-9786"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Spetz, Johan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Helou, Khalil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helou, Khalil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069898768","display_name":"Eva B. Forssell-Aronsson","orcid":"https://orcid.org/0000-0002-7558-4368","observed_orcids":["https://orcid.org/0000-0002-7558-4368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Forssell-Aronsson, Eva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.43566249,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.6304000020027161,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.6304000020027161,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.32710000872612,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.01549999974668026,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/177lu-octreotate","display_name":"177Lu-octreotate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/late-apoptosis","display_name":"late apoptosis","score":0.6150000095367432},{"id":"https://openalex.org/keywords/hyperfractionated-radiotherapy","display_name":"hyperfractionated radiotherapy","score":0.8130000233650208},{"id":"https://openalex.org/keywords/small-intestinal-neuroendocrine-tumors","display_name":"small bowel neuroendocrine tumors","score":0.875},{"id":"https://openalex.org/keywords/apoptosis-related-gene-expression","display_name":"apoptosis-related gene expression","score":0.7850000262260437},{"id":"https://openalex.org/keywords/ripk2","display_name":"RIPK2","score":0.9879999756813049},{"id":"https://openalex.org/keywords/tumor-regrowth","display_name":"tumor regrowth","score":0.7490000128746033},{"id":"https://openalex.org/keywords/radiopharmaceutical-therapy","display_name":"radiopharmaceutical therapy","score":0.6100000143051147},{"id":"https://openalex.org/keywords/peptide-receptor-radionuclide-therapy","display_name":"peptide receptor radionuclide therapy","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6331999897956848},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.6134999990463257},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.555400013923645},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5389999747276306},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4377000033855438},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36899998784065247},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.3653999865055084},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34790000319480896},{"id":"https://openalex.org/C48023723","wikidata":"https://www.wikidata.org/wiki/Q856198","display_name":"Real-time polymerase chain reaction","level":3,"score":0.33709999918937683},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.322299987077713},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.32030001282691956},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.31520000100135803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3151000142097473},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3001999855041504},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2653000056743622},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.2624000012874603}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:figshare.com:article/29891767","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Late_apoptotic_effects_after_treatment_with_sup_177_sup_Lu-octreotate_in_small-intestine_neuroendocrine_GOT1_tumor_model/29891767","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"doi:10.6084/m9.figshare.29891767","doi":"https://doi.org/10.6084/m9.figshare.29891767","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.29891767","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"article-journal"},{"id":"doi:10.6084/m9.figshare.29891767.v1","doi":"https://doi.org/10.6084/m9.figshare.29891767.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.29891767.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/29891767","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Late_apoptotic_effects_after_treatment_with_sup_177_sup_Lu-octreotate_in_small-intestine_neuroendocrine_GOT1_tumor_model/29891767","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6596751809120178}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Therapy":[0],"with":[1,56,98,150],"hyperfractionated":[2,74],"administration":[3,15],"of":[4,9,16,20,34,42,140,145,175,217,229],"177Lu-octreotate":[5,57,219],"gave":[6],"larger":[7],"reductions":[8],"GOT1":[10,48,69,93],"tumor":[11,81,118],"volume":[12,119],"than":[13],"single":[14,72],"the":[17,40,123,169,183,186,189,195,215,227,232],"same":[18],"amount":[19],"radiopharmaceutical.":[21],"The":[22,32,76,158,177,199,205,221],"molecular":[23,212],"mechanisms":[24],"behind":[25],"this":[26,35],"response":[27,213],"need":[28],"to":[29,38,63,163],"be":[30],"examined.":[31],"aims":[33],"work":[36],"were":[37,95,114,125,197,201],"compare":[39,64],"expression":[41,66,139],"genes":[43,193],"involved":[44],"in":[45,47,67,152,168,185,194,211,231],"apoptosis":[46],"tumors":[49,70,128],"during":[50],"growth":[51],"phase":[52],"from":[53,59],"mice":[54,124],"treated":[55,96],"and":[58,62,73,85,121,127,133,209],"untreated":[60,164],"mice,":[61,91],"gene":[65,147,181],"regrown":[68],"after":[71],"administration.":[75],"study":[77,187,196,206],"was":[78,131,148,156,166,188],"performed":[79],"on":[80,226],"samples":[82],"previously":[83],"collected":[84],"analyzed":[86,134],"by":[87,135],"other":[88],"methods.":[89],"BALB/c":[90],"bearing":[92],"tumors,":[94],"i.v.":[97],"2x15":[99],"MBq":[100,111,174],"or":[101,104,109],"1x30;":[102],"2x30":[103],"1x60":[105],"MBq;":[106],"3x40,":[107],"2x60,":[108],"1x120":[110],"177Lu-octreotate.":[112,176],"Controls":[113],"given":[115],"saline.":[116],"After":[117],"reduction":[120],"regrowth,":[122],"euthanized":[126],"collected,":[129],"RNA":[130],"extracted":[132],"PCR":[136],"Array":[137],"for":[138],"84":[141],"apoptosis-related":[142],"genes.":[143],"Expression":[144],"each":[146],"compared":[149,162],"that":[151,171],"controls.":[153],"Pathway":[154],"analysis":[155],"performed.":[157],"highest":[159],"regulated":[160,180],"gene,":[161],"controls,":[165],"RIPK2":[167],"group":[170],"received":[172],"3x40":[173],"most":[178],"frequently":[179],"among":[182],"groups":[184,216],"pro-apoptotic":[190],"TNFSF8.":[191],"Most":[192],"upregulated.":[198],"\u2502FC\u2502-values":[200],"all":[202],"below":[203],"3.5.":[204],"present":[207],"similarities":[208],"differences":[210],"between":[214],"different":[218],"treatments.":[220],"results":[222],"may":[223],"have":[224],"impact":[225],"optimization":[228],"therapy":[230],"future.":[233]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}